head JofIMAB
Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski Publishing Ltd.
ISSN: 1312-773X (Online)
Issue: 2019, vol. 25, issue2
Subject Area: Medicine
DOI: 10.5272/jimab.2019252.2583
Published online: 27 June 2019

Original article

J of IMAB. 2019 Apr-Jun;25(2):2583-2588
Dmitry Kapitanov1ORCID logo, Anastasia Kostousova1ORCID logo Corresponding Autoremail, Marina Nersesyan1ORCID logo, Dilyana Vicheva2ORCID logo,
1) Department of Otorhinolaryngology, Burdenko Neurosurgical Institut,. Moscow, Russian Federation,
2) Department of Otorhinolaryngology, Medical Faculty, Medical University, Plovdiv, Bulgaria.

Fibrous dysplasia (FD) is a rare benign bone tumor characterized by replacement of normal bone by fibro-osseous connective tissue. FD accounted for 7 % of all the benign bone tumors. The incidence of FD involving the sinonasal tract is unknown.
The purpose of this study was to assess the incidence of sinonasal involvement by FD, to analyze the clinical characteristics, radiological features, and management of patients with fibrous dysplasia in order to understand the indications for surgical treatment. We also present some CT images of our patients to demonstrate typical radiographic signs of FD.
Materials and methods: a retrospective review of 19 patients. Distribution of the cases according to the clinical and radiological features was described, management and results were presented.
Results: among 78 patients with craniofacial FD, 19 (24, 36%) patients presented sinonasal involvement. The average age was 47 years. 1patient was with monostotic form, the rest 18 – with polyostotic. The most common site of the lesion was sphenoid and ethmoid sinuses, the most common complaint – headache, less often – nasal obstruction with or without nasal discharge.16 patients underwent purely endoscopic removal, the rest 3 – combined neurosurgery with endoscopic assistance. Median follow-up period was 21 months, and there were no continued growth in our observed group.
Conclusions: FD is a very rare pathology. In this particular group of patients, endoscopic treatment showed a good result, but this pathology still needs to be further studied, and patients require a long-term follow-up. Endoscopic surgery is challenging as FD bleeds freely, and should be only contemplated by an experienced rhinologist.

Keywords: Fibrous dysplasia, sinonasal fibrous dysplasia, skull base, functional endoscopic sinus surgery,

pdf - Download FULL TEXT /PDF 1085 KB/
Please cite this article as: Kapitanov D, Kostousova A, Nersesyan M, Vicheva D. Sinonasal fibrous dysplasia: our 10-years experience.. J of IMAB. 2019 Apr-Jun;25(2):2583-2588.
DOI: 10.5272/jimab.2019252.2583

Corresponding AutorCorrespondence to: Kostousova Anastasia, Department of Otorhinolaryngology, Burdenko Neurosurgical Institut,. Moscow, Russian Federation; E-mail: kostousova@yahoo.com

1. Lund, VJ, Stammberger H, Nicolai P, Castelnuovo P. European position paper on endoscopic management of tumours of the nose, paranasal sinuses and skull base. Rhinol Suppl. 2010 Jun;22:1-143. [PubMed]
2. Thompson LDR, Wenig BM. Diagnostic Pathology: Head and Neck. Published by Amirsys. Lippincott Williams & Wilkins. 1 edition. March 9, 2011. 1075 p. [Internet]
3. Wu H, Yang L, Li S, Jin X, Xu J, Lu J, et al. Clinical characteristics of craniomaxillofacial fibrous dysplasia. J Craniomaxillofac Surg. 2014 Oct;42(7):1450-5. [PubMed] [Crossref]
4. Yang L, Wu H, Lu J, Teng L. Prevalence of Different Forms and Involved Bones of Craniofacial Fibrous Dysplasia. J Craniofac Surg. 2017 Jan;28(1):21-25. [PubMed] [Crossref]
5. Hanifi B, Samil KS, Yasar C, Cengiz C, Ercan A, Ramazan D. Craniofacial fibrous dysplasia. Clin Imaging. 2013 Nov-Dec;37(6):1109-15. [PubMed] [Crossref]
6. Duan C, Dai Q, Liu Q, Yu H. Characteristics of sinonasal fibrous dysplasia: experience from a single department. Acta Otolaryngol. 2018 Jan;138(1):50-55. [PubMed] [Crossref]
7. Amit M, Collins MT, FitzGibbon EJ, Butman JA, Fliss DM, Gil Z. Surgery versus watchful waiting in patients with craniofacial fibrous dysplasia—a meta-analysis. PLoS One. 2011 Sep;6(9):e25179. [PubMed] [Crossref]
8. Gupta D, P Garg, A Mittal. Computed Tomography in Craniofacial Fibrous Dysplasia: A Case Series with Review of Literature and Classification Update. Open Dent J. 2017 Jun;11:384-403. [PubMed] [Crossref]
9. Wang Y, Wang O, Jiang Y, Li M, Xia W, Meng X, et al. Efficacy and Safety of Bisphosphonate Therapy in Mccune-Albright Syndrome Related Polyostotic Fibrous Dysplasia: A Single-Center Experience. Endocr Pract. 2019 Jan;25(1):23-30. [PubMed] [Crossref]
10. Chapurlat RD, Delmas PD, Liens D, Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. J Bone Miner Res. 1997 Oct;12(10):1746-52. [PubMed] [Crossref]
11. Metwally T, Burke A, Tsai JY, Collins MT, Boyce AM. Fibrous Dysplasia and Medication-Related Osteonecrosis of the Jaw. J Oral Maxillofac Surg, 2016 Oct; 74(10):1983-99. [PubMed] [Crossref]
12. Kim S, Jung DW, Pak MG, Song YJ, Bae WY. An Aneurysmal Bone Cyst in the Skull Base. J Craniofac Surg. 2017 Oct;28(7):e704-e706. [PubMed] [Crossref]
13. Macdonald-Jankowski DS. Focal cemento-osseous dysplasia: a systematic review. Dentomaxillofac Radiol. 2008 Sep;37(6):350-60. [PubMed] [Crossref]
14. Topouchian V, Mazda K, Hamze B, Laredo JD, Pennecot GF. Aneurysmal bone cysts in children: complications of fibrosing agent injection. Radiology. 2004  Aug;232(2):522-6. [PubMed] [Crossref].

Received: 08 December 2018
Published online: 27 June 2019

back to Online Journal